Sounder than a lifecycle device: Prosonix takes on Novartis (and the rest)
This article was originally published in Scrip
Executive Summary
Oxford, UK-based respiratory drug development company Prosonix (slogan - 'Revolutionising Respiratory Medicine') is squaring up to take on pharma giant Novartis, according to CEO David Hipkiss. "Fundamentally I know we're right, and I know we cannot be argued with, because we have the scientific high ground. It sounds a bit arrogant, but it's true!"